Compound Detail
CHEMBL2105695
TELOTRISTAT ETHYL 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
CCOC(=O)[C@@H](N)Cc1ccc(-c2cc(O[C@H](c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)nc(N)n2)cc1
Basic Information
| ChEMBL ID | CHEMBL2105695 |
| Name | TELOTRISTAT ETHYL |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | MDSQOJYHHZBZKA-GBXCKJPGSA-N |
| Therapeutic | ✓ Yes |
| Active Moiety | CHEMBL2103855 |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
20
Publications
8
Known Names
6
Indications
1
Mechanisms
Molecular Properties
575.0
MW (Da)
4.99
ALogP
9
HBA
2
HBD
131.2
PSA (Ų)
0.27
QED
1
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2017 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Tryptophan 5-hydroxylase inhibitor | INHIBITOR | Tryptophan 5-hydroxylase | ✓ | ✓ |
Indications
Carcinoid Heart Disease Biliary Tract Neoplasms Malignant Carcinoid Syndrome Neuroendocrine Tumors Pancreatic Neoplasms Liver Diseases
Activity Summary
IC50 2 meas. best 6.14
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Tryptophan 5-hydroxylase 2 CHEMBL5433 | IC50 | 6.14 | 6.14 | 730.0 | 1 |
| Tryptophan 5-hydroxylase 1 CHEMBL5689 | IC50 | 6.11 | 6.11 | 770.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Tryptophan 5-hydroxylase 2 | IC50 | = | 730.0 | nM | 6.14 | In Vitro Enzyme Activity Assay: The full-length coding sequences of human TPH1 a... | - |
| Tryptophan 5-hydroxylase 1 | IC50 | = | 770.0 | nM | 6.11 | In Vitro Enzyme Activity Assay: The full-length coding sequences of human TPH1 a... | - |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Androgen receptor | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Estrogen receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Peroxisome proliferator-activated receptor gamma | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Neuronal acetylcholine receptor subunit alpha-4 | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-1 adrenergic receptor | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Kappa-type opioid receptor | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2C | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Adenosine receptor A1 | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | D(2) dopamine receptor | 1 |
Data from ChEMBL 36 via Core Engine